Literature DB >> 17091400

Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.

Alethéa G Barschak1, Angela Sitta, Marion Deon, Marcella H de Oliveira, Alexsandro Haeser, Carlos S Dutra-Filho, Moacir Wajner, Carmen R Vargas.   

Abstract

Maple syrup urine disease (MSUD) or branched-chain alpha-keto aciduria (BCKA) is an inherited disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKAD) activity. The blockage of this pathway leads to tissue accumulation of the branched-chain amino acids (BCAA) leucine, isoleucine and valine and their respective keto-acids. The clinical features presented by MSUD patients include ketoacidosis, convulsions, coma, psychomotor delay and mental retardation. The mechanism of brain damage in this disease is still poorly understood. However, an increase in lipid peroxidation in vitro in cerebral cortex of young rats as well as a decrease in the antioxidant defenses has been previously observed. In the present work we evaluated different oxidative stress parameters, named reactive species of thiobarbituric acid (TBARS), total antioxidant reactivity (TAR) and total antioxidant status (TAS) in plasma of MSUD patients in order to evaluate whether oxidative stress is involved in this disorder. We verified a marked increase of plasma TBARS measurements, which is indicative of increased lipid peroxidation, as well as a decrease on plasma TAR reflecting a deficient capacity to efficiently modulate the damage associated with an increased production of reactive species. In contrast, TAS was not changed indicating that the total content of antioxidants in plasma of patients affected by MSUD was not altered. These results suggest that free radical generation is elicited in MSUD and is possibly involved in the pathophysiology of the tissue damage found in this disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17091400     DOI: 10.1007/s11011-006-9030-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  31 in total

1.  Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease.

Authors:  R G Tavares; C E Santos; C I Tasca; M Wajner; D O Souza; C S Dutra-Filho
Journal:  J Neurol Sci       Date:  2000-12-01       Impact factor: 3.181

2.  Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.

Authors:  E Treacy; C L Clow; T R Reade; D Chitayat; O A Mamer; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 3.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements.

Authors:  E Lissi; M Salim-Hanna; C Pascual; M D del Castillo
Journal:  Free Radic Biol Med       Date:  1995-02       Impact factor: 7.376

5.  A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates.

Authors:  N J Miller; C Rice-Evans; M J Davies; V Gopinathan; A Milner
Journal:  Clin Sci (Lond)       Date:  1993-04       Impact factor: 6.124

6.  Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.

Authors:  P Jouvet; P Rustin; D L Taylor; J M Pocock; U Felderhoff-Mueser; N D Mazarakis; C Sarraf; U Joashi; M Kozma; K Greenwood; A D Edwards; H Mehmet
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

7.  The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defense.

Authors:  E Karelson; N Bogdanovic; A Garlind; B Winblad; K Zilmer; T Kullisaar; T Vihalemm; C Kairane; M Zilmer
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

8.  Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease.

Authors:  Estefanía Méndez-Alvarez; Ramón Soto-Otero; Alvaro Hermida-Ameijeiras; Ana María López-Real; José Luis Labandeira-García
Journal:  Biochim Biophys Acta       Date:  2002-03-16

9.  Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: alpha-ketoisocaproate infusion.

Authors:  H R Zielke; Y Huang; J T Tildon; C L Zielke; P J Baab
Journal:  Dev Neurosci       Date:  1996       Impact factor: 2.984

10.  Effect of leucine administration on creatine kinase activity in rat brain.

Authors:  Carmen Pilla; Rui Felipe de Oliveira Cardozo; Carlos Severo Dutra-Filho; Angela Terezinha Souza Wyse; Moacir Wajner; Clóvis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2003-03       Impact factor: 3.584

View more
  29 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.

Authors:  Giselli Scaini; Meline O S Morais; Leticia S Galant; Francieli Vuolo; Dhébora M Dall'Igna; Matheus A B Pasquali; Vitor M Ramos; Daniel P Gelain; Jose Claudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Francisco G Soriano; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

3.  Neuroprotective Effect of Creatine and Pyruvate on Enzyme Activities of Phosphoryl Transfer Network and Oxidative Stress Alterations Caused by Leucine Administration in Wistar Rats.

Authors:  Elenara Rieger; Itiane Diehl de Franceschi; Thales Preissler; Clovis Milton Duval Wannmacher
Journal:  Neurotox Res       Date:  2017-06-13       Impact factor: 3.911

4.  Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.

Authors:  Giselli Scaini; Meline O S Morais; Camila B Furlanetto; Luiza W Kist; Talita C B Pereira; Patrícia F Schuck; Gustavo C Ferreira; Matheus A B Pasquali; Daniel P Gelain; José Cláudio F Moreira; Maurício R Bogo; Emilio L Streck
Journal:  Neurochem Res       Date:  2015-02-14       Impact factor: 3.996

5.  Investigation of L - Carnitine Concentrations in Treated Patients with Maple Syrup Urine Disease.

Authors:  Burcu Kumru; Burcu Oztürk Hismi
Journal:  J Pediatr Genet       Date:  2019-05-28

Review 6.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

7.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09

8.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

9.  Oxidative stress in plasma from maple syrup urine disease patients during treatment.

Authors:  Alethéa G Barschak; Angela Sitta; Marion Deon; Amanda T Barden; Carlos S Dutra-Filho; Moacir Wajner; Carmen R Vargas
Journal:  Metab Brain Dis       Date:  2007-11-17       Impact factor: 3.584

10.  Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid.

Authors:  Patrícia Fernanda Schuck; Estela Natacha Brandt Busanello; Alana Pimentel Moura; Anelise Miotti Tonin; Mateus Grings; Luciana Ritter; Carmen Regla Vargas; Gustavo da Costa Ferreira; Moacir Wajner
Journal:  Neurochem Res       Date:  2009-09-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.